Eli Lilly announced that its breakthrough drug, Mounjaro (tirzepatide), has received marketing authorization from India’s apex drug regulator, the Central Drugs Standard Control Organisation (CDSCO).
Hosted on MSN
Eli Lilly Launches Mounjaro KwikPen in India; Is It Better Than Taking a Jab to Battle Diabetes and Obesity?
Eli Lilly has launched Mounjaro KwikPen, a trizetrapib for those battling type 2 diabetes and obesity, in India. According to the pharmaceutical giant, this multi-dose, single-patient-use, prefilled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback